In human somatic cells proliferation results in telomere shortening due to the end replication problem and the absence of adequate levels of telomerase activity. The progressive loss of telomeric DNA has been associated with replicative senescence. Maintenance of telomere structure and function is, therefore, an essential requisite for cells that proliferate indefinitely. Human cells that have acquired the immortal phenotype mostly rely on telomerase to compensate for telomere shortening with cell division. However, a certain percentage of immortalized cell lines and human tumors maintain their telomeres by Alternative Lengthening of Telomeres (ALT), a mechanism not fully understood but apparently based on homologous recombination. Here, we report the isolation of an immortal human cell line that is derived from an ALT cell line but maintains telomeres in the absence of key features of ALT and of telomerase. The properties of these cells suggest that the identification of ALT cells may not be reliably based on known ALT markers. This finding is of relevance for discriminating between the mortal and immortal phenotype among telomerase-negative cells in vitro and in vivo, particularly in regard to the development of pharmacological approaches for cancer treatment based on telomerase inhibition.
Introduction
Telomeres are nucleoprotein structures that cap the ends of eukaryotic chromosomes and are involved in the protection of chromosome ends from fusion, illegitimate recombination and degradation (Zakian, 1995; Kurenova and Mason, 1997) . Both components of the telomeres, telomeric DNA and associated proteins, are essential for their structure and function. In normal human cells telomeres shorten with cell division due to the inability of conventional DNA polymerases to replicate the extremities of the chromosomes, and this shortening leads to a permanent growth arrest called replicative senescence (Watson, 1972; Olovnikov, 1973; Harley et al., 1990) . Cells with indefinite replicative potential, such as germ line and stem cells as well as tumor cells, must therefore prevent or overcome the loss of telomeric sequences. Human cells have at least two mechanisms to maintain their telomeres: a more prevalent one mediated by telomerase, and a less frequent one, called Alternative Lengthening of Telomeres (ALT), presumably based on homologous recombination and copy switching (Murnane et al., 1994; Bryan et al., 1995; Dunham et al., 2000) . Telomerase is an RNA-dependent DNA polymerase that adds de novo telomeric repeats to the chromosome termini. The active enzyme minimally contains an RNA subunit (hTR in humans) with a template region that is copied into the telomeres, and a catalytic subunit (hTERT in humans) with reverse transcriptase activity (Weinrich et al., 1997; Beattie et al., 1998; Nugent and Lundblad, 1998) . In humans, telomerase is active in all cells during embryonic development. In the adult telomerase contributes to telomere maintenance in germ line and stem cells, whereas in most somatic cells, even when present, it does not prevent telomere loss (Collins, 2000; Masutomi et al., 2003) . Moreover, telomerase is reactivated in over 90% of human tumors and in a large percentage of immortalized cell lines (Bryan and Reddel, 1997; Shay and Bacchetti, 1997) . In telomerase-positive cells, telomeres are usually short and homogeneous in size.
Although less frequent than telomerase, ALT has been found to maintain telomeres in at least 30-40% of immortalized human cell lines and 10-15% of human tumors (Bryan et al., 1995 (Bryan et al., , 1997a Bryan and Reddel, 1997) . There is substantial evidence that ALT is based on homologous recombination (Henson et al., 2002) , however, the precise mechanism of this form of telomere maintenance is not yet known. Therefore, cells using ALT are identified on the basis of markers that have been frequently associated with this process. Unlike cells expressing telomerase, ALT cells are characterized by very long (up to 50 kb) and heterogeneous telomeres and by the presence of nuclear bodies, ALT-associated PML bodies (APBs), which in addition to the PML protein contain telomeric DNA, telomere-binding proteins such as TRF1 and TRF2, and proteins involved in DNA repair and recombination (Bryan et al., 1995; Yeager et al., 1999; Grobelny et al., 2000; Wu et al., 2000) . The role of APBs has not been elucidated yet, but their specific presence in ALT-positive cells and tumors has rendered them a useful marker for the activation of the ALT pathway (Yeager et al., 1999; Henson et al., 2005) . In addition, ALT cells can be identified by a high rate of post-replicative exchanges between the telomeres of sister chromatids, T-SCE (Bailey et al., 2004a; Bechter et al., 2004; London˜o-Vallejo et al., 2004) and by the presence of extra-chromosomal telomeric DNA circles not detectable in normal or in telomerasepositive cells (Cesare and Griffith, 2004; Wang et al., 2004) .
Here we report the isolation and characterization of an immortalized human cell line, C3-cl6, whose phenotype differs from that of both telomerase-positive and ALT cells. Although C3-cl6 cells are derived from ALT cells and lack biologically active telomerase, they maintain telomeres that are short and homogeneous in size, unlike those typically associated with ALT. Moreover, although retaining the T-SCE phenotype, C3-cl6 cells lack two additional markers of the ALT pathway: APBs and extra-chromosomal telomeric DNA. The properties of these cells suggest that telomere maintenance in human cells may be more diverse than previously thought.
Results

C3-cl6 cells lack the long heterogeneous telomeres typical of ALT cells
ALT cells are immortal cells that maintain telomeres through a mechanism presumably based on homologous recombination. They do not express telomerase, due to the lack of hTERT or both hTERT and hTR (Bryan et al., 1997b; Counter et al., 1998b; Wen et al., 1998) . Previous studies from several laboratories including ours have shown that telomerase can be reconstituted in ALT cells by reintroducing the missing component/s (Counter et al., 1998b; Wen et al., 1998) and that these cells can utilize concomitantly both mechanisms of telomere maintenance Grobelny et al., 2001; Perrem et al., 2001) . We have also shown that the introduction in ALT VA13/2RA cells of wildtype hTR (wt-hTR) and a mutant form of telomerase, hTERT-HA, which is biologically inactive but retains catalytic activity in vitro (Counter et al., 1998a) , did not affect cell proliferation and viability (Guiducci et al., 2001) . Most of the hTR þ /hTERT-HA þ clones retained the telomere length heterogeneity typical of ALT cells, indicating that expression of hTERT-HA had no influence on this parameter (data not shown). Surprisingly, we found one clone, C3-cl6, with short and homogeneous telomeres (Figure 1a and b) . The average TRF length in these cells was much shorter than in parental VA13-C3 cells (5 kb versus 13 kb), and the telomere profile was characterized by the absence of very long telomeres (>20 kb) (Figure 1c ). Analysis at the single-cell level by FISH also showed pronounced telomere length homogeneity with absence of very long telomeres accompanied by little variation in single telomere length and a marked reduction in the percentage of chromosome ends without telomeric signal compared to the parental cells (Figure 1d and data not shown). These findings suggest that in C3-cl6 cells ALT may have been suppressed. Strikingly, however, the cells continue proliferating and to date have gone through more than 300 population doublings (PDs) maintaining short and stable telomeres (Figure 1b ).
C3-cl6 cells do not express wild-type telomerase
TRF and FISH hybridizations indicated that C3-cl6 cells have homogeneous telomeres similar to those of telomerase-positive cells. We reasoned that if the ALT pathway were suppressed, C3-cl6 cells might be under strong selective pressure to reactivate endogenous telomerase. To investigate this possibility, we performed RT-PCR with two primers that recognize specifically the endogenous hTERT (Armbruster et al., 2001) . As shown in Figure 2a , endogenous hTERT was clearly detected in telomerase-positive HeLa cells, but not in the parental or C3-cl6 cells. Both VA13-C3 and C3-cl6 cell lines retained expression of the mutant telomerase hTERT-HA and in C3-cl6 cells the enzyme was still catalytically active in vitro (Figure 2b ). DNA sequencing of hTERT-HA from C3-cl6 cells confirmed the absence of mutations that could lead to reactivation of the biological function of the enzyme (data not shown).
Telomeres in C3-cl6 cells are not maintained by hTERT-HA
Although the mutant telomerase hTERT-HA has been shown incapable of maintaining telomeres in human cells due to the presence of the HA tag at its C-terminus, a limited increase (8-10 PDs) in lifespan was reported in two clones with high levels of hTERT-HA expression (Counter et al., 1998a) . This suggests that the presence of the tag may not completely abolish the in vivo functions of the mutant protein. Therefore, one possible explanation for the telomere profile and the sustained proliferation of C3-cl6 cells could be related to a minimal activity of hTERT-HA sufficient to maintain stable telomeres. To investigate this aspect, we interfered with telomerase activity by (i) expressing a mutant hTR with a single point mutation in the template region (MuA-hTR) (Marusic et al., 1997) , and (ii) using the telomerase-specific inhibitor BIBR1532 (Damm et al., 2001) . If hTERT-HA is involved in telomere length maintenance in these cells, the presence of MuA-hTR should result in the incorporation of mutated repeats into the telomeres (Marusic et al., 1997) and in reduced cell viability, as previously shown (Guiducci et al., 2001) . Similarly, if hTERT-HA maintains telomeres in C3-cl6 cells, treatment of the cells with BIBR1532 should result in inhibition of telomerase activity and in telomere shortening over time (Damm et al., 2001) .
The introduction of MuA-hTR in C3-cl6 cells, although reconstituting an in vitro active mutant enzyme Mutated repeats specified by MuA-hTR are not incorporated into the telomeres in C3-cl6 cells. TRF analysis of vector and MuA-hTR expressing C3-cl6 clones with either a MuA-specific telomeric probe (a) or wt telomeric probe (b) at PD 28-30 after transfection of MuA-hTR. pBSdT34 was used as a positive control for the hybridization with the mutant probe. VA13-C3 cl5, a MuA-hTR expressing clone of parental VA13-C3 cells, is used as a control for inactive telomerase Figure 4 (a) BIBR1532 does not have any effect on C3-cl6 telomeres. TRF analysis of VA13-C3, C3-cl6 and HA1-IM cells grown in normal medium (nt), medium with DMSO or with the telomerase inhibitor BIBR1532 for 28-32 PDs. BIBR-1 and BIBR-2 indicate two independent samples of C3-cl6 cells. Representative molecular weight markers are indicated. (b) BIBR1532 inhibits telomerase activity in vitro. Telomerase activity of C3-cl6 and HA1-IM cells assayed without additions (nt) or in the presence of DMSO or BIBR (2.5 mM). In all cases 25 and 50 ng of extracts were assayed. IC indicates the internal control telomerase-positive HA1 cells with 2.5 mM of BIBR1532 for 28-32 PDs and analysed telomere length. As shown in Figure 4a , BIBR treatment resulted in marked telomere shortening in HA1 cells, while no effect was observed in VA13-C3 cells. Similarly, telomere length was maintained during drug treatment in C3-cl6 cells, although the BIBR1532 dose used was sufficient to inhibit telomerase activity in vitro (Figure 4b ). Similar results were obtained when we overexpressed a dominant-negative hTERT (dn-hTERT) to inhibit telomerase activity in C3-cl6 cells (data not shown), indicating that hTERT-HA has no residual biological activity. This conclusion is also supported by the recent observation that the N-and C-terminal regions of telomerase are important for the interaction of the telomerase RNP with telomeric DNA, and that mutations in these regions result in enzymes that, although catalytically active in vitro, are incapable of maintaining telomere length in vivo (Lee et al., 2003) .
Taken together, these results clearly demonstrate that hTERT-HA is not biologically active in these cells and indicate that C3-cl6 cells maintain telomeres through a mechanism that is not telomerase dependent.
C3-cl6 cells lack most markers of classical ALT cells
Since the molecular mechanism of ALT is not yet known, identification of ALT cells relies on markers that have been frequently associated with this process. Among such markers are specific nuclear bodies or APBs, whose presence has been correlated with an active ALT pathway (Yeager et al., 1999; Henson et al., 2005) and whose frequency decreases significantly upon ALT suppression (Perrem et al., 2001; Jiang et al., 2005) . Analysis of the co-localization of TRF2 and PML proteins by immunofluorescence was used to monitor the presence of APBs in C3-cl6 cells. As shown in Figure 5a , APBs were detected in the parental VA13-C3 cells but not in C3-cl6 cells at either early or late PDs. On the other hand, APBs were detected in all hTR þ / hTERT-HA þ clones that had a typical ALT telomere profile (data not shown), supporting the conclusion that C3-cl6 cells have lost this marker of classical ALT.
The recent observation that human ALT cells contain extra-chromosomal telomeric DNA circles suggests that ALT may be based on a roll and spread mechanism whereby the telomeric circles are used as template for (Figure 5b ). Circular telomeric DNAs were also present in VA13-C3 cells from which C3-cl6 were derived (Figure 5b ). In contrast with that, telomeric circles could not be detected in C3-cl6 cells even when higher DNA concentrations were analysed (Figure 5b) .
Chromosome orientation fluorescence in situ hybridization (CO-FISH) (reviewed in Bailey et al., 2004b) has revealed that ALT cells have a high frequency of postreplicative telomeric exchanges, T-SCE, which are detected as double signals at each chromosome extremity (London˜o-Vallejo et al., 2004) . T-SCE and hence double signals are absent or extremely rare in non-ALT cells. The high frequency of T-SCE, which appears to be an ALT-specific marker (Bechter et al., 2004; London˜o-Vallejo et al., 2004) , may be the consequence of unrestrained recombination at the telomeres. We performed CO-FISH analysis on C3-cl6 cells and found that they retained this ALT feature (Figure 6 ), suggesting that recombination at telomeres has not been repressed. However, as for classical ALT cells, it is not known whether telomeric exchanges are taking place between sister chromatid telomeres or between telomeres located on different chromosomes.
C3-cl6 cells do not have subtelomeric amplification
Recombinational mechanisms of telomere maintenance have been extensively characterized in the unicellular eukaryote Saccharomyces cerevisiae, which normally uses telomerase to maintain telomeres. Upon inactivation of telomerase most yeast cells die within a limited number of divisions but rare survivors arise which are able to maintain telomeres through recombination. These survivors can be distinguished into type I and type II based on their telomere structure. Type I survivors have short telomeres that are maintained by recombination in the telomere-associated Y 0 element, while type II survivors have very long and heterogeneous telomeres that are likely maintained by intertelomeric recombination (Teng and Zakian, 1999; Teng et al., 2000; Chen et al., 2001) . Human ALT cells are reminiscent of type II survivors in yeast (Lundblad and Blackburn, 1993; Bryan et al., 1995 Bryan et al., , 1997a Teng and Zakian, 1999) . Since C3-cl6 cells have shorter telomeres than ALT cells, we investigated the possibility of a type I-like activity in these cells. For this purpose, we used two human sub-telomeric specific probes (TelBam3.4 and TelBam11; Chute et al., 1997) to detect amplification in the sub-telomeric region in C3-cl6 cells. As shown in Figure 7a , there is no difference in the pattern and intensity of sub-telomeric signals between parental and C3-cl6 cells with either probe, suggesting that there is no amplification of the sub-telomeric region in C3-cl6 cells.
Since the subtelomeric probes used are specific for only a subset of human chromosomes (Chute et al., 1997) , they would not detect amplification on other chromosomes. To assess if such amplification occurred, we measured TRF size in both cell lines after digestion of genomic DNA with a panel of rare cutting enzymes, separation by PFGE and hybridization with a telomeric probe. TRF size was measured by densitometric analysis and the lengths of sub-telomeric and telomeric regions were calculated as described in Materials and methods. As shown in Figure 7b and c, digestion of genomic DNA with SwaI or NotI yielded sub-telomeric regions of comparable length for C3-cl6 and parental cells, confirming the results of the previous experiment. Similar results were obtained with other rare cutting restriction enzymes (data not shown). From these data, we concluded that C3-cl6 cells do not use a type I-like mechanism to maintain stable telomeres.
Discussion
Telomere length maintenance is an essential prerequisite for indefinite cell proliferation (Bacchetti and Counter, 1995; Holt et al., 1997) . Loss of telomeric DNA during cell division or telomere malfunction cause growth arrest and ultimately cell death. Therefore, immortal cells activate some mechanism to maintain telomeres. Two possible mechanisms for telomere length main- tenance have been reported so far in human cells: telomerase and ALT. Telomerase is the most common, being present in >90% of human tumors and in a vast majority of immortalized cell lines (Bryan and Reddel, 1997; Shay and Bacchetti, 1997) . ALT, on the other hand, has been detected in a subset of human tumors and in about 40% of in vitro immortalized cell lines (Bryan et al., 1995 (Bryan et al., , 1997a Bryan and Reddel, 1997) .
In this study, we report the isolation and characterization of an immortal human cell line that may maintain telomeres through an atypical form of ALT. C3-cl6 cells are derived from an ALT cell line and lack active telomerase, but have short telomeres without the length heterogeneity typically observed in ALT cells. In addition, C3-cl6 cells do not contain APBs, a marker of active ALT in human cell lines and human tumors (Yeager et al., 1999; Henson et al., 2005) nor the extrachromosomal telomeric DNA circles, easily detected in the parental cells and found in a variety of ALT cell lines (Cesare and Griffith, 2004; Wang et al., 2004) . These findings suggest that ALT can occur in the absence of the above markers, or that in C3-cl6 cells the classical ALT pathway may have been suppressed. In the latter case, selective pressure for survival on C3-cl6 cells could have resulted in either reactivation of endogenous telomerase or mutation of hTERT-HA to a biologically active enzyme. However, our results showed that endogenous telomerase is not expressed in these cells and that hTERT-HA is not mutated. In addition, we confirmed that the mutant telomerase, although catalytically active in vitro, is not biologically active in maintaining telomere length. We also ruled out the possibility of telomere maintenance by a type I-like mechanism, based on the observation that the subtelomeric regions in C3-cl6 cells are not amplified compared to parental cells. Interestingly, C3-cl6 cells still bear high rates of telomere exchanges, T-SCE, as classical ALT cells, suggesting that a recombinationbased mechanism of telomere maintenance may still be occurring. Since telomeric DNA circles are not present in C3-cl6 cells, it is unlikely that recombination involves extra-chromosomal material. Moreover, transfer of telomeric DNA between sister chromatids or different chromosomes (Bailey et al., 2004a) should have only a temporary effect on telomere maintenance and survival in C3-cl6 cells given the homogenous and short size of their telomeres. An ALT cell line that lacks APBs but retains other features of ALT has recently been described (Fasching et al., 2005; Marciniak et al., 2005) , strengthening our conclusion that the use of the known ALT markers needs to be reassessed. Most relevant, absence of both telomerase and classical ALT has been reported in a high percentage of human osteosarcomas and found associated with improved patient survival, suggesting that lack of telomere maintenance mechanisms may represent a positive prognostic factor (Ulaner et al., 2003) . The existence of immortal cells such as C3-cl6 that mimic this phenotype has important implications for the understanding of modified or new forms of telomere maintenance in human cells, for the development of specific assays to assess their frequency among immortalized cell lines and tumors, and for pharmacological approaches to cancer treatment based on telomerase inhibition.
Materials and methods
Cells and transfections
VA13/2RA are SV40-transformed human WI38 cells that lack both subunits of telomerase and use ALT for telomere maintenance. They were obtained from ATCC and grown in a-MEM with 10% fetal calf serum (FCS, Gibco BRL). C3-cl6 cells were generated by transfecting VA13/2RA with the mutant telomerase hTERT-HA protein (VA13-C3 cells) Genomic DNA was digested with rare cutting restriction enzymes, separated by PFGE and hybridized with a telomeric probe. Representative molecular weight markers are indicated. S, SwaI; N, NotI; B, BamHI; E, EcoRV. In the lower panel, a schematic representation of the sizes of telomeric and subtelomeric regions in C3-cl6 and VA13-C3 cells calculated as described in Material and methods is shown. (c) The distribution of TRF sizes for SwaI and NotI digestions shown in (b) was quantified as in Figure 1 followed by wt-hTR (Marusic et al., 1997) . phTR-MuA containing the puromycin resistance gene and a mutant hTR gene specifying TTTGGG telomeric sequences (Guiducci et al., 2001 ) (Geron Corp., Menlo Park, CA, USA), and pLX-dnhTERT, encoding a dominant-negative hTERT (Hahn et al., 1999) and the puromycin resistance gene, were used to over-express MuA-hTR and dn-hTERT in C3-cl6 cells. All clonal populations were subcultured at a 1 : 4 split ratio as they reached confluence, and PDs were determined taking arbitrarily as 0 the first confluent 60 mm plate after clonal isolation.
HA1 (Counter et al., 1992) and HeLa cells were grown in a-MEM with 10% FCS. For BIBR1532 treatment, VA13-C3, C3-cl6 and HA1 cells were left untreated or grown in the presence of DMSO alone or plus 2.5 mM of BIBR1532 (Boehringer Ingelheim, Austria, GmbH) for 28-32 PDs.
Telomerase assay
Indicated protein amounts from whole-cell extracts were assayed by TRAP assay (Kim et al., 1994) . For telomerase activity specified by hTR-MuA, 5 mg of extracts were used in the assay using conditions and primers described for this mutant (Feng et al., 1995) . For BIBR1532 treatment, TRAP assay was performed in the presence or absence of the compound or vehicle (Damm et al., 2001 ).
Immunofluorescence
For co-localization of PML and TRF2, as previously described , cells fixed in 1% formaldehyde and permeabilized with 0.25% Triton X-100 were incubated overnight with a goat polyclonal antibody against PML (N19, Santa Cruz, USA; 2mg/ml) and a rabbit polyclonal antibody against TRF2 (Grobelny et al., 2000) (1 : 50 dilution). The primary antibodies were detected with FITC-conjugated donkey anti-goat IgG and Cy3-conjugated donkey anti-rabbit antibodies (Jackson Immuno Research) respectively, at 1 : 100 dilution for 1 h at room temperature. Nuclei were stained with 1 mg/ml Hoechst 33258 and cells were analysed by confocal microscopy.
DNA analysis
For TRF analysis, DNA was digested with HinfI/RsaI or rare cutting restriction enzymes (NotI, HhaI, SwaI, BamHI, EcoRV) and 2-4 mg of DNA were separated by PFGE (Bryan et al., 1995) . Following in gel DNA denaturation and partial gel drying, the DNA was hybridized with a [g-32 P]-dATP 5 0 end-labeled telomeric probe and the gel exposed to a PhosphoImager. Hybridization signals were quantified with ImageQuant (Molecular Dynamics) as described (Harley et al., 1990; Bryan et al., 1995) . The size of subtelomeric regions in C3-cl6 and VA13-C3 cells was calculated by subtracting from the average lengths obtained after digestion by each rare cutting enzyme (telomere þ extended sub-telomere), the average lengths obtained after HinfI/RsaI digestion (telomere þ minimal sub-telomere, Figure 1) . Detection of mutant sequences in telomeres was performed using 5-8 mg of genomic DNA and hybridization with a mutant-specific probe. pBSdT34, containing nine TTTGGG repeats (Marusic et al., 1997) , was used as a positive control for hybridization with the mutant probe.
For Southern blot analysis, genomic DNA was digested with EcoRI/BamHI, separated on 0.8% agarose gel and hybridized with labeled sub-telomeric probes, TelBam3.4 and TelBam11 (Chute et al., 1997) .
For two-dimensional PFGE (2D-PFGE), 20-35 mg of genomic DNA was used. DNA was separated in the first dimension on a 0.5% agarose gel for 25 h and in the second dimension on a 1.1% agarose gel for 8 h as previously described (Cesare and Griffith, 2004) . The gels were hybridized with a [g-32 P]-dATP 5 0 end-labeled telomeric probe and exposed to PhosphorImager and autoradiography.
Reverse transcriptase-polymerase chain reaction Total RNA was isolated using TRIzol (Invitrogen). The following primers were used: for hTERT-HA (HA(1), 5 0 -ATG GCTGCGTGGTGAACTTG-3 0 and HA(2), 5 0 -ACATCGTA TGGGTAGTCCAG-3 0 ); for endogenous hTERT (Armbruster et al., 2001 ) (ehTERT1, 5 0 -ACTCGACACCGTGTCACCTA-3 0 and ehTERT2, 5 0 -GTGACAGGGCTGCTGGTGTC-3 0 ); for human GAPDH (RT11, 5 0 -CGGAGTCAACGGATTTG GTCGTAT-3 0 and RT12, 5 0 TGCTAAGCAGTTGGTGGT GCAGGA-3 0 ).
Q-FISH and CO-FISH
Q-FISH analysis on VA13-C3 and C3-cl6 cells was performed as previously described . For CO-FISH analysis cells were incubated with BrdU (30 mM) for 1 doubling time before metaphase preparation. Slides were treated as described (Cornforth and Eberle, 2001 ) and hybridized with a fluorescein-labeled (CCCTAA) 3 PNA probe. To increase sensitivity, telomeric fluorescent signals were amplified by successive incubations with the following antibodies: anti-FITC (mouse), FITC-labeled anti-mouse (rat) and FITClabeled anti-rat (donkey).
